Skip to main content

Highlights

  1. 1
    Clinical and translational medicine · 2025
    PMID: 39856363PMCID: PMC11761363DOISenior author
  2. 2
    Advances in experimental medicine and biology · 2022
    PMID: 35230691PMCID: PMC10311991DOISenior author8 citations
  3. 3
    Cell reports. Medicine · 2025
    PMID: 40628262PMCID: PMC12281429DOIeCommonsSenior author1 citations

Publications

63 publications

Active

4 grants
  • PI
    Targeting Cullin-RING E3 ubiquitin ligase 1 to treat ovarian cancer
    Mary Kay Foundation, The · 2025–2027
    MKF 10-25
  • Co-I
    Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1
    CTSC Cost Share · 2022–2027
    UL1TR002384-06
  • PI
    Amgen Contract No. 5209583
    Amgen Inc. · 2025–2026BioPharma Alliance
    BP 262629-01
  • Co-I
    Diversifying Patient-Derived Tumor Organoids
    Parker Institute for Cancer Immunotherapy · 2024–2026
    PICI IC-594
Completed grants (2)
  • PI
    Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
    NCI · 2019–2022 · via NIH RePORTER
    R00CA230384-04
  • PI
    Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
    National Cancer Institute · 2018–2019
    K99CA230384-01

News mentions

External relationships

Ownership

FAETH Therapeutics

Proprietary Interest

FAETH Therapeutics

Other

FAETH Therapeutics